Computationally Optimized SARS-CoV-2 MHC Class I and II Vaccine Formulations Predicted to Target Human Haplotype Distributions
Ge Liu, Brandon Carter, Trenton Bricken, Siddhartha Jain, Mathias Viard, Mary Carrington, David K. Gifford
Topics & Concepts
HaplotypeSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Coronavirus disease 2019 (COVID-19)2019-20 coronavirus outbreakComputational biologyMajor histocompatibility complexBiologyClass (philosophy)MHC class IGeneticsVirologyComputer scienceGeneArtificial intelligenceGenotypeMedicineOutbreakDiseasePathologyInfectious disease (medical specialty)vaccines and immunoinformatics approachesSARS-CoV-2 and COVID-19 ResearchMonoclonal and Polyclonal Antibodies Research